(Q40220185)

18 September 2017

title

BSACI guidelines for the management of chronic urticaria and angio-oedema (English)

1 reference

18 September 2017

1 reference

1 reference

R J Powell

1

1 reference

18 September 2017

G L Du Toit

2

1 reference

18 September 2017

N Siddique

3

1 reference

18 September 2017

S C Leech

4

1 reference

18 September 2017

T A Dixon

5

1 reference

18 September 2017

A T Clark

6

1 reference

18 September 2017

R Mirakian

7

1 reference

18 September 2017

S M Walker

8

1 reference

18 September 2017

P A J Huber

9

1 reference

18 September 2017

S M Nasser

10

1 reference

18 September 2017

British Society for Allergy and Clinical Immunology (BSACI)

11

1 reference

18 September 2017

publication date

1 May 2007

1 reference

Clinical & Experimental Allergy

18 September 2017

published in

1 reference

18 September 2017

volume

37

1 reference

18 September 2017

issue

5

1 reference

18 September 2017

page(s)

631-650

1 reference

The impact of chronic urticaria on the quality of life.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Chronic urticaria: aetiology, management and current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Clinical practice. Chronic urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Morphologic assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Integration of inflammatory signals by rolling neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

High prevalence of autoimmune urticaria in children with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Chronic urticaria: novel clinical and serological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Urticaria and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Hepatitis C virus infection in patients with urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Testing for hepatitis B virus in patients with chronic urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Consensus meeting on the definition of physical urticarias and urticarial vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Chronic urticaria: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Drug-induced angioedema without urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

ACE inhibitor-induced angioedema. Incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Incidence and characteristics of angioedema associated with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Late angio-oedema in patients taking angiotensin-converting-enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

C1 inhibitor deficiency: consensus document

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

21 January 2018

Urticaria: then and now.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Outpatient management of acute urticaria: the role of prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Advances in H1-antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Urticarial intolerance reaction to cetirizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Cetirizine: a review of its use in allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Zafirlukast has no beneficial effects in the treatment of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Clinical guidelines: developing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Methotrexate-responsive chronic idiopathic urticaria: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Stanozolol in chronic urticaria: a double blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Warfarin treatment of chronic idiopathic urticaria and angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Montelukast-induced generalized urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Management and diagnostic guidelines for urticaria and angio-oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Suspected tartrazine-induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Chronic urticaria: association with thyroid autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Prevalence of silent coeliac disease in atopics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Chronic urticaria in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

First-trimester drug use and congenital disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2007.02678.X

10.1111/J.1365-2222.2007.02678.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference